The potential role of MALAT1 in the treatment of lung cancer could be further evaluated by conducting experiments in mice using MALAT1 inhibitors followed by the simultaneous application of cancer impact factors in a control group. This evidence concerns the gene MALAT1 and lung carcinoma.